The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.
Profilee Satyajit Mayor discusses his explorations of cell membranes, which are helping to update the classical fluid mosaic model of dynamic cellular boundaries.